The effect of intermittent and continuous clorgyline administration on locomotor sensitization induced by the dopamine agonist quinpirole
Culver, K.E.; Szechtman, H.
Society for Neuroscience Abstracts 25(1-2): 1214
1999
ISSN/ISBN: 0190-5295 Accession: 035874493
PDF emailed within 1 workday: $29.90
Related References
Culver, K.E.; Szechtman, H. 1997: Chronic clorgyline administration blocks the development and attenuates the maintenance of quinpirole-induced locomotor sensitization Society for Neuroscience Abstracts 23(1-2): 2405Culver, K.E.; Szechtman, H. 2003: Clorgyline-induced switch from locomotion to mouthing in sensitization to the dopamine D2/D3 agonist quinpirole in rats: role of sigma and imidazoline I2 receptors Psychopharmacology 167(2): 211-218
Culver, K.E.; Szechtman, H. 2004: Hypophysectomy does not block sensitization to the dopamine agonist quinpirole or its modulation by the MAOi clorgyline Hormones and Behavior 45(1): 23-30
Zhou, L.W.; Milligan, C.; Weiss, B. 1989: Down regulation of stereotypy and development of locomotor behavior following the continuous administration of the dopamine d 2 agonist quinpirole in mice FASEB Journal 3(4): A1045
Johnson, E.F.; Szechtman, H. 2016: A dose-response study of separate and combined effects of the serotonin agonist 8-OH-DPAT and the dopamine agonist quinpirole on locomotor sensitization, cross-sensitization, and conditioned activity Behavioural Pharmacology 27(5): 439-450
Jung, T.D.; Jung, P.S.; Raveendran, L.; Farbod, Y.; Dvorkin-Gheva, A.; Sakic, B.; Surette, M.G.; Szechtman, H. 2018: Changes in gut microbiota during development of compulsive checking and locomotor sensitization induced by chronic treatment with the dopamine agonist quinpirole Behavioural Pharmacology 29(2 and 3-Spec Issue): 211-224
Einat, H..; Szechtman, H.. 1993: Environmental modulation of both locomotor response and locomotor sensitization to the dopamine agonist quinpirole Behavioural Pharmacology 4(4): 399-403
Perreault, M.L.; Graham, D.; Scattolon, S.; Wang, Y.; Szechtman, H.; Foster, J.A. 2007: Cotreatment with the kappa opioid agonist U69593 enhances locomotor sensitization to the D2/D3 dopamine agonist quinpirole and alters dopamine D2 receptor and prodynorphin mRNA expression in rats Psychopharmacology 194(4): 485-496
Beerepoot, P.; Lam, V.; Luu, A.; Tsoi, B.; Siebert, D.; Szechtman, H. 2008: Effects of Salvinorin A on Locomotor Sensitization to D2/D3 Dopamine Agonist Quinpirole Neuroscience Letters 446(2-3): 101-104
Lomanowska, A.; Gormley, S.; Szechtman, H. 2004: Presynaptic stimulation and development of locomotor sensitization to the dopamine agonist quinpirole Pharmacology Biochemistry and Behavior 77(3): 617-622
Einat, H.; Einat, D.; Allan, M.; Talangbayan, H.; Tsafnat, T.; Szechtman, H. 1996: Associational and nonassociational mechanisms in locomotor sensitization to the dopamine agonist quinpirole Psychopharmacology 127(2): 95-101
Szechtman, H.; Dai, H.; Mustafa, S.; Einat, H.; Sullivan, R.M. 1994: Effects of dose and interdose interval on locomotor sensitization to the dopamine agonist quinpirole Pharmacology Biochemistry and Behavior 48(4): 921-928
Engber, T.M.; Susel, Z.; Chase, T.N. 1989: Continuous and intermittent administration of skf 38393 or quinpirole differentially affect d 1 and d 2 agonist induced rotation Society for Neuroscience Abstracts 15(2): 1315
Jake Matthews, C.; Vezina, P. 1995: Cues specifically unpaired with amphetamine attenuate the development of locomotor sensitization to the D-2 dopamine receptor agonist quinpirole Society for Neuroscience Abstracts 21(1-3): 2089
Szechtman, H..; Talangbayan, H..; Eilam, D.. 1993: Environmental and behavioral components of sensitization induced by the dopamine agonist quinpirole Behavioural Pharmacology 4(4): 405-410
King, G.R.; Xue, Z.; Calvi, C.; Ellinwood, E.H. 1995: 5-HT3 agonist-induced dopamine overflow during withdrawal from continuous or intermittent cocaine administration Psychopharmacology 117(4): 458-465
Perreault, M.L.; Graham, D.; Bisnaire, L.; Simms, J.; Hayton, S.; Szechtman, H. 2006: Kappa-opioid agonist U69593 potentiates locomotor sensitization to the D2/D3 agonist quinpirole: pre- and postsynaptic mechanisms Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 31(9): 1967-1981
Culver, K.E.; Szechtman, H. 1998: Quinpirole-induced locomotor sensitization Involvement of a MAOI-displaceable quinpirole binding site Society for Neuroscience Abstracts 24(1-2): 1442
D'Aquila, P.S.; Peana, A.T.; Tanda, O.; Serra, G. 2001: Carbamazepine prevents imipramine-induced behavioural sensitization to the dopamine D(2)-like receptor agonist quinpirole European Journal of Pharmacology 416(1-2): 107-111
Culver, K.E.; Rosenfeld, J.M.; Szechtman, H. 2002: Monoamine oxidase inhibitor-induced blockade of locomotor sensitization to quinpirole: Role of striatal dopamine uptake inhibition Neuropharmacology 43(3): 385-393